Compare

Two peptides, one row at a time.

Pick any two indexed peptides. The URL captures your selection - paste it in a deck, an email, a paper. The view stays the same for any reader who opens it.

Peptide A

Mecasermin (IGF-1, Increlex)

verifiedBioGate · GREEN
severe primary IGF-1 deficiency (FDA approved)
Peptide B

BPC-157

verifiedBioGate · GREENGrade B
soft-tissue recovery
Identity
  • Sequence≠
    GPETLCGAELVDALQFVCGDRGFYFNKPTGYGSSSRRAPQTGIVDECCFRSCDLRRLEMYCAPLKPAKSA
    GEPPPGKPADDAGLV
  • Length≠
    70 aa
    15 aa
  • Molecular weight≠
    7649.00
    1419.55
  • Modifications≠
    recombinant human IGF-170-residue3 disulfide bridges
    acetyl-N-terminus
  • Mechanism

    Recombinant insulin-like growth factor 1; binds IGF-1R to promote longitudinal bone growth and tissue anabolism.

    Pentadecapeptide derived from human gastric juice; modulates VEGF and growth-hormone receptor expression in injured tissue.

Provenance
  • BioGate
    verifiedBioGate · GREEN
    verifiedBioGate · GREEN
  • PDA-V1 outer≠
  • Inputs hash≠
  • Model version
    structure-fm-2026.04
    structure-fm-2026.04
  • PDA candidates
    4
    4
Outcomes
  • RWE cohorts≠
    none
    5
  • Total participants≠
    -
    270
  • Primary endpoint Δ≠
    -
    -1.7 Δ HRV ms (8-week)
    95% CI [-2.46, -0.94]
  • LOO posterior≠
    34.1%
    β(27.5, 53.2)
    88.1%
    β(33.8, 4.6)
  • Top-grade citations≠
    Grade B1 of 1
    Grade B2 of 2
Economics
  • IPNFT≠
    Molecule IPNFT V2
    Solana · 307 holders
    Molecule IPNFT V2
    Solana · 73 holders
  • Royalty cascade≠
    8.98%
    10.04%
Indications
  • Listed indications≠
    • · severe primary IGF-1 deficiency (FDA approved)
    • · growth promotion in pediatric IGFD
    • · soft-tissue recovery
    • · GI mucosal repair
    • · tendon healing